HopeStage
Back to all studies
RecruitingNCT07328373

Biological predictors of depression relapse after stopping antidepressants

About this titleRead the official source — NCT07328373
Observational studyAges 18–65Türkiye
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
IstanbulSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 1, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
204
Sponsor
Mehmet Kemal Arikan
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Drug
Locations
Türkiye
Age range
From 18 Years to 65 Years
Official registry ID
NCT07328373
Official title
Show the full official title

Neurobiological and Genomic Predictors of Relapse After Discontinuation of Antidepressant Treatment in Major Depressive Disorder: An Observational Prospective Study

Recruitment & locations

Currently recruiting

Istanbul, Türkiye · Türkiye

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Mehmet Kemal Arikan.

Does this study involve medication?

Yes. The study involves medication, including Antidepressant Medications.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies